Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function

被引:194
作者
Fuxe, K [1 ]
Ferré, S
Canals, M
Torvinen, M
Terasmaa, A
Marcellino, D
Goldberg, SR
Staines, W
Jacobsen, KX
Lluis, C
Woods, AS
Agnati, LF
Franco, R
机构
[1] Karolinska Inst, Dept Neurosci, Div Cellular & Mol Neurochem, Stockholm, Sweden
[2] Univ Barcelona, Dept Biochem & Mol Biol, E-08007 Barcelona, Spain
[3] Univ Ottawa, Ottawa, ON K1N 6N5, Canada
[4] NIDA, DHHS, NIH, Intramural Res Program, Baltimore, MD 21224 USA
[5] Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy
关键词
adenosine A(2A) receptors; dopamine D-2 receptors; heteromers; Parkinson's disease; schizophrenia;
D O I
10.1385/JMN:26:2-3:209
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The existence of A(2A)-D-2 heteromeric complexes is based on coimmunoprecipitation studies and on fluorescence resonance energy transfer and bioluminescence resonance energy transfer analyses. It has now become possible to show that A(2A) and D-2 receptors also coimmunoprecipitate in striatal tissue, giving evidence for the existence of A(2A)-D-2 heteromeric receptor complexes also in rat striatal tissue. The analysis gives evidence that these heteromers are constitutive, as they are observed in the absence of A(2A) and D-2 agonists. The A(2A)-D-2 heteromers, could either be A(2A)-D-2 heterodimers and/or higher-order A(2A)-D-2 hetero-oligomers. In striatal neurons there are probably A(2A)-D-2 heteromeric complexes, together with A(2A)-D-2 homomeric complexes in the neuronal surface membrane. Their stoichiometry in various microdomains will have a major role in determining A(2A) and D-2 signaling in the striatopallidal GABA neurons. Through the use of D-2/D-1 chimeras, evidence has been obtained that the fifth transmembrane (TM) domain and/or the I3 of the D2 receptor are part of the A(2A)-D-2 receptor interface, where electrostatic epitope-epitope interactions involving the N-terminal part of I3 of the D-2 receptor (arginine-rich epitope) play a major role, interacting with the carboxyl terminus of the A(2A) receptor. Computerized modeling of A(2A)-D-2 heteromers are in line with these findings. It seems likely that A(2A) receptor-induced reduction of D-2 receptor recognition, G protein coupling, and signaling, as well as the existence of A(2A)-D-2 co-trafficking, are the consequence of the existence of an A(2A)-D-2 receptor heteromer. The relevance of A(2A)-D-2 heteromeric receptor complexes for Parkinson's disease and schizophrenia is emphasized as well as for the treatment of these diseases. Finally, recent evidence for the existence of antagonistic A(2A)-D-3 heteromeric receptor complexes in cotransfected cell lines has been summarized.
引用
收藏
页码:209 / 219
页数:11
相关论文
共 58 条
  • [1] Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons
    Agnati, LF
    Ferré, S
    Lluis, C
    Franco, R
    Fuxe, K
    [J]. PHARMACOLOGICAL REVIEWS, 2003, 55 (03) : 509 - 550
  • [2] AGNATI LF, 1980, MED BIOL, V58, P182
  • [3] The adenosine A2A receptor agonist CGS 21680 exhibits antipsychotic-like activity in Cebus apella monkeys
    Andersen, MB
    Fuxe, K
    Werge, T
    Gerlach, J
    [J]. BEHAVIOURAL PHARMACOLOGY, 2002, 13 (08): : 639 - 644
  • [4] Adenosine A2A receptor antagonist treatment of Parkinson's disease
    Bara-Jimenez, W
    Sherzai, A
    Dimitrova, T
    Favit, A
    Bibbiani, F
    Gillespie, M
    Morris, MJ
    Mouradian, MM
    Chase, TN
    [J]. NEUROLOGY, 2003, 61 (03) : 293 - 296
  • [5] Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch
    Bofill-Cardona, E
    Kudlacek, O
    Yang, Q
    Ahorn, H
    Freissmuth, M
    Nanoff, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (42) : 32672 - 32680
  • [6] Adenosine A2A-dopamine D2 receptor-receptor heteromerization -: Qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer
    Canals, M
    Marcellino, D
    Fanelli, F
    Ciruela, F
    de Benedetti, P
    Goldberg, SR
    Neve, K
    Fuxe, K
    Agnati, LF
    Woods, AS
    Ferré, S
    Lluis, C
    Bouvier, M
    Franco, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (47) : 46741 - 46749
  • [7] Homodimerization of adenosine A2A receptors:: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer
    Canals, M
    Burgueño, J
    Marcellino, D
    Cabello, N
    Canela, EI
    Mallol, J
    Agnati, L
    Ferré, S
    Bouvier, M
    Fuxe, K
    Ciruela, F
    Lluis, C
    Franco, R
    [J]. JOURNAL OF NEUROCHEMISTRY, 2004, 88 (03) : 726 - 734
  • [8] Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization.: Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors
    Ciruela, F
    Burgueño, J
    Casadó, V
    Canals, M
    Marcellino, D
    Goldberg, SR
    Bader, M
    Fuxe, K
    Agnati, LF
    Lluis, C
    Franco, R
    Ferré, S
    Woods, AS
    [J]. ANALYTICAL CHEMISTRY, 2004, 76 (18) : 5354 - 5363
  • [9] Adenosine A(2A) receptors modulate the binding characteristics of dopamine D-2 receptors in stably cotransfected fibroblast cells
    Dasgupta, S
    Ferre, S
    Kull, B
    Hedlund, PB
    Finnman, UB
    Ahlberg, S
    Arenas, E
    Fredholm, BB
    Fuxe, K
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 316 (2-3) : 325 - 331
  • [10] Díaz-Cabiale Z, 2001, NEUROREPORT, V12, P1831